Meeder Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$367K Buy
1,125
+147
+15% +$47.9K 0.02% 440
2025
Q1
$264K Buy
978
+72
+8% +$19.4K 0.02% 483
2024
Q4
$213K Sell
906
-27
-3% -$6.35K 0.01% 525
2024
Q3
$257K Buy
+933
New +$257K 0.02% 473